Biotechnology Market Research Reports & Consulting

discount on Mnm

Market Reports

Title Published Price TOC Available

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018

The choice of cells depends on various technical and economic aspects. E. coli, Bacillus subtitlus, and yeast are the most preferred bacteria as they are easier to grow, independent, and have metabolic capabilities. On the other hand, animal cells are fragile, larger than microorganisms and difficult to grow. Another important driver is the development of vaccines; influenza vaccines have been previously developed with the help of egg-based technology. However, due its labor-intensive approach, this has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture.

July 2014 $ 4650 selected

Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019

Over the last decade, there has been a tremendous development in biochemistry and molecular biology which has had a positive impact on the overall growth of the metabolomics market. The market has witnessed the introduction of many advanced analytical equipment and data processing programs.

June 2014 $ 4650 selected

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

The global isothermal nucleic acid technology (INAAT) market is estimated to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. The market growth is primarily attributed to increasing demand for advanced isothermal based molecular testing over conventional thermal polymerase chain reaction (PCR) technology.

May 2014 $ 4650 selected

Sample Preparation Market by Product [Instruments (Workstations, Liquid Handling Systems), Consumables (Tubes), Kits (Isolation, Purification)], Application (Genomics, Proteomics) & by End Users (Molecular Diagnostics) - Global Forecast to 2018

The global sample preparation market is segmented on the basis of products, applications, and end users. Based on products the global sample preparation market includes instruments, consumables, accessories and sample preparation kits. Instruments are further classified into sample preparation workstations, liquid handling systems, extraction systems and others. Liquid handling systems comprises liquid handling workstations, pipetting systems, reagent dispensers, microplate washers and others.

May 2014 $ 4650 selected

Human Identification Market by Technology (Next Generation Sequencing, Rapid DNA Analysis, Capillary Electrophoresis, PCR), Application (Forensics, Paternity Testing), DNA Amplification, Quantification, Extraction, Services, & Software - Forecast to 2018

The global human identification market was valued at an estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years. This high growth is mainly attributed to the rising need to reduce time and cost of DNA analysis, government support in the form of funding, rapid technological advancements, and conferences and symposiums related to usage of new technologies in DNA profiling.

May 2014 $ 4650 selected

Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018

The cell-based assay market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of drug. The global cell-based assay market is growing at a CAGR of 11.1% from 2013 to 2018 and poised to reach $14.8 billion by 2018. The global cell based assay market is segmented on the basis of products, applications, end users and geography.

May 2014 $ 4650 selected

Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 2018

Label-free technologies are increasingly used in drug discovery for the detection and characterization of molecular interactions. The inherent advantages of label-free technology over alternative technologies like ELISA and flow cytometry are a significant factor driving its adoption. The label-free detection is a highly sensitive method used for detection of endogenous targets in cell assays, and eliminates the need for reporter labels like dyes, tags, or specialized reagents. Use of labels may confound data due to steric hindrance, and quenching. Conventional label-based technologies are usually labor intensive, cumbersome and time consuming.

April 2014 $ 4650 selected

Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018

Protein expression is an essential component of proteomics that plays an important role in research by allowing the expression of genetically engineered recombinant proteins in various host cells. The protein expression market includes reagents, expression vectors, and competent cells used for transfection and maintenance of competent cells. As a result of the declining R&D rate of productivity and the sales drop expected by the upcoming patent cliff, the growing research intensity in the pharmaceutical sector will be an important growth driver for this market during the forecast period between 2013 and 2018. In addition, the development in the biologics and proteomics market will boost the research in protein expression, thus being a vital growth driver.

April 2014 $ 4650 selected

Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation) & by End Users - Global Forecasts to 2018

The global nucleic acid isolation and purification market is valued at $ 2,103.39 million and is poised to grow at a CAGR of 8.11% from 2013 to 2018. The technological advancements and government support through funding for research activities will be the two most important growth drivers for this market in the forecast period from 2013 to 2018.

April 2014 $ 4650 selected

Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018

The global cell analysis market is segmented on the basis of products, applications, end users, and geography. The products market is further segmented into instruments and consumables. Based on applications, the cell analysis market is divided into Cell identification, cell interaction, cell viability, cell proliferation, cell structure studies, cell signaling pathway/signal transduction, cell counting and quality control, target identification and validation, and single cell analysis. Based on end users, the cell analysis market is categorized into hospitals, academics and government institutes, laboratories, contract research organizations (CROs), pharmaceutical and biotechnology companies, and others. Based on geography, this market is divided into North America, Europe, Asia, and the Rest of the World (RoW).

April 2014 $ 4650 selected

Atomic Spectroscopy Market by Technology ( X-Ray Fluorescence / Atomic Absorption / X-Ray Diffraction / ICP-MS ) & by Application ( Food & Beverage / Pharmaceutical / Industrial Chemistry / Biotechnology / Environment ) - Competitive Landscape - Global Forecasts & Trends to 2018

The demand for atomic spectroscopy instrumentation has been quite robust due to its wide arena of applications. Technologies like X-Ray Fluorescence (XRF) and X-Ray Diffraction (XRD) have important quality control applications in the detection of hazardous elements in consumable commercial goods, semiconductors, and electronics, among others.

April 2014 $ 4650 selected

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018

The global molecular spectroscopy market is segmented on the basis of products, applications, and geography. Based on products, the market includes NMR Spectroscopy, Ultraviolet-Visible Spectroscopy (UV-Vis), Infrared Spectroscopy (IR), Near Infrared (NIR) Spectroscopy, Color Spectroscopy, Raman Spectroscopy, and others. The NMR Spectroscopy segment is further classified into Continuous Wave spectroscopy, Fourier Transform spectroscopy, and Solid-State spectroscopy. The Ultraviolet-Visible Spectroscopy (UV-Vis) segment comprises Single-beam spectroscopy, Dual-beam spectroscopy, Array-based spectroscopy, and Handheld spectroscopy. The IR market by spectrum includes short-wave Infrared spectroscopy, mid-wave Infrared spectroscopy, and far-wave Infrared spectroscopy.

April 2014 $ 4650 selected

In-Vitro Toxicology Testing Market by Industry (Diagnostic, Pharmaceutical, Cosmetics, Chemical), Technology (Cell Culture, HTS, Omics), Applications (Systemic, Dermal, Ocular), Method (Cellular Assay, Ex vivo, In Silico) - Global Forecast to 2018

The market will witness a double-digit growth attributed to the increasing acceptance of in vitro methods over in vivo ones. Government support to stop animal testing, new and promising technologies, and advancement in new approaches are significant factors propelling the market in the forecast period.

April 2014 $ 4650 selected

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018

The proteomics market showcases a high growth potential, owing to the growing awareness about personalized medicine and the resultant increase in the use of proteomic technologies-based advancement in the pharmaceutical industry.

March 2014 $ 4650 selected

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

The global POC diagnostics market is broadly categorized into infectious diseases testing kits, glucose monitoring kits, coagulation monitoring kits, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs of abuse testing kits, cardiac markers, blood gas/electrolytes testing kits, tumor/cancer markers, pregnancy and fertility testing kits, fecal occult testing kits, food pathogens testing kits, and others.

March 2014 $ 4650 selected

Mass Spectrometry Market - by Technology (Tandem LC - MS/ Quadrupole/ ICP - MS/ Gas Chromatography - MS/ TOF - MS/ MALDI -TOF/ Fourier Transform - MS) & by Application (Pharmaceutical/ Biotechnology/ Environment/ Food & Beverages) - Global Trends & Forecast to 2018

The mass spectrometry market has evolved from basic research in the early 20th century to a host of applications consisting of pharmaceutical development, cancer research, petroleum refining & security and monitoring. Development of improved ionization sources increased the applicability of the instruments. Pharmaceuticals, proteomics, biomarker research form the largest market for Mass Spectrometry, however, environmental testing, petroleum refining, security and semiconductor & electronics segments also contribute largely to the market.

March 2014 $ 4650 selected

Particle Size Analysis Market by Technology (Laser Diffraction, Dynamic Light Scattering, Imaging, Coulter Principle, Nanoparticle Tracking Analysis), Industry (Healthcare, Chemical, Petroleum, Mining, Mineral, Food) & End User - Global Forecasts to 2018

Based on the type of technology, the global particle size analyzers market is categorized into six segments, namely, laser diffraction, dynamic light scattering, imaging, Coulter Principle, nanoparticle tracking analysis, and others. The others segment comprises resonant mass measurement, sedimentation, sieve analysis, and laser obscuration. The laser diffraction technology segment accounted for the largest share of 35.0% of the global particle size analyzers market in 2013. However, the imaging technology segment is expected to grow at the highest CAGR in the next five years, owing to the advancements in imaging technologies.

March 2014 $ 4650 selected

Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nanofiltration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) - Trends & Forecast to 2018

The global pharmaceutical membrane filtration market is segmented on the basis of technology, application, and region. The technology segments included in the report are microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion exchange; the application segments are cell separation, protein purification, sterilization, virus removal, and water management; while the geographic segments are North America, Europe, Asia-Pacific, and Rest of the World (RoW).

March 2014 $ 4650 selected

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018

The global gene expression analysis market is segmented into instrumentation, consumables, and services. Based on technologies, the gene expression analysis instrumentation market is further segmented into DNA microarrays, real-time PCR, next-generation sequencing, and others.

February 2014 $ 4650 selected

Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018

The future growth prospects for the protein crystallization & crystallography market are optimistic and it is estimated to grow at a CAGR of 10.1% to reach a worldwide market of $1,253 million by 2018. The increasing use of crystallization for membrane protein structure elucidation, increasing R&D by big pharmaceutical and biotechnology firms, technological advancements, and increasing government funding are all factors that are expected to fuel the growth of the protein crystallization & crystallography market in the near future. However, insufficiency of qualified and experienced researchers, lack of generalized crystallization methods associated with the types of proteins, and highly time-consuming and expensive protein crystallization and crystallography processes are expected to hinder the growth of this market during the forecasted period. The key unmet market needs provide huge opportunities for both, the key players and new entrants in this industry.

February 2014 $ 4650 selected

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

The global high content screening market is segmented on the basis of products, applications, end users, and geography. The products market is further segmented into instruments, consumables, software, and services. Based on applications, the high content screening market is divided into primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and other applications. Based on end users, the high content screening market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs). Based on geography, this market is divided into North America, Europe, Asia, and the Rest of the World (RoW).

February 2014 $ 4650 selected

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018

The global HTS market was valued at $13.7 billion in 2013 and is expected to grow at a CAGR of 7.4% over the next five years. A number of factors such as technological innovations, increasing adoption of open innovation models by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations are driving the growth of this market. The HTS market is segmented on the basis of technology, products, applications, end users, and geography. The global HCS market report studies the market estimations and trends for the above mentioned segments in four geographies, namely, North America, Europe, Asia, and RoW (Rest of the World). The growth in outsourcing of drug discovery services, especially in China and India, and the presence of a large untapped market in emerging countries are the factors that are expected to present growth opportunities to players in the HTS market. However, factors such as the capital intensive nature of HTS and difficulties in assay development for novel target classes are hampering the growth of this market.

February 2014 $ 4650 selected

Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018

“Genomics may be defined as the study of chromosomes, genes, and their functions in search of aspects helpful in spotting, preventing, or controlling disease through drug treatments or vaccinations” – Ontario Genomics Institute. This genomics market study is segmented by product (Instruments, Consumables, and Services), by technology (Nucleic acid extraction & purification, PCR, DNA sequencing, and DNA microarray), by application (Diagnostics, Drug discovery, Academic research, Agriculture& Animal research, Personalized medicine, and others), and by geography (North America, Europe, APAC, and RoW).

January 2014 $ 4650 selected

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

The global mice model market is segmented on the basis of type, technology, disease, and mice model services. By type, the mice model market comprises of inbred, outbred, knockout, conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice.

January 2014 $ 4650 selected

Chromatography Accessories and Consumables Market by Types (Columns, Autosamplers, Vials, Detectors, Fraction Collectors, Pressure Regulators, Degassers), by Technology (LC (HPLC, UHPLC, Flash), GC), by End-users - Trends & Global Forecasts to 2018

The global chromatography accessories and consumables market is a technology-driven market where technologies as well as their adoption by end users witness a rapid change. This market is expected to grow at a CAGR of 5.7% from 2013 to 2018, to reach $3.5 billion by 2018.

December 2013 $ 4650 selected

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018

The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormone; whereas the recombinant glycosylated proteins market is further broken down into erythropoietin, monoclonal antibodies, and follitropin.

November 2013 $ 4650 selected

Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global Forecast to 2018

Immunoassays have evolved as an integral part of the modern medical care practice owing to the continuous technological advancements in this field, the increase in healthcare awareness among people, and the increasing use of immunoassay tests in diagnosis and monitoring.

October 2013 $ 4650 selected

Chromatography Instrumentation Market by Systems [LC (HPLC, UHPLC, FLASH), GC, TLC, SFC, Others (Autosamplers, Detectors, Fraction collectors)], by Consumables (Reverse phase columns, Syringe filters, Vials) & Industry - Global Forecast to 2018

The global chromatography instrumentation market is segmented on the basis of systems, consumables, end users, and geography. The chromatography systems market comprises liquid chromatography systems, gas chromatography systems, supercritical fluid chromatography systems, thin layer chromatography systems, and other components of systems (detectors, autosamplers, pumps, and fraction collectors).

October 2013 $ 4650 selected

Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018

Cancer/Tumor profiling is a promising market and is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018.

September 2013 $ 4650 selected

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)

A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic response to a therapeutic intervention. Biomarkers are classified in different ways based on different parameters such as on the basis of their application, their characteristics and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of developing drugs and rise in the failure rate for drugs in phase II and III clinical trials, biomarkers are being employed on large scale by pharmaceutical companies to overcome these challenges. Also the advent of personalized medicine and companion diagnostics is witnessing a strong presence of use of biomarkers and holds to be a big opportunity for the overall biomarker market.

September 2013 $ 4650 selected

Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017

A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2000 years ago, when Romans, Chinese, and Aztecs used gold for dental applications. Biomaterials, which are also biocompatible, have since been adapted, improvised, and technically enabled to improve body functions and replace damaged tissues. They have evolved to include biodegradable materials that are easily dissolved in the body. Advances in technology and the emergence of innovative biomaterial products have enhanced their performance and applications.

September 2013 $ 4650 selected

Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018

Nerve repair and regeneration market is categorized into the peripheral nerve repair segment and the neuromodulation segment. The peripheral nerve repair segment consists of direct nerve repair, nerve grafting, and stem cell therapy, while neuromodulation is divided into external and internal neuromodulation segments. The nerve repair market is expected to grow at a strong CAGR during the study period.

September 2013 $ 4650 selected

Chromatography Reagents Market By Type [Alkylation, Acylation, Solvent, Buffer], Bed Shape [Column, Thin layer], Mobile Phase [HPLC, UHPLC, HILIC, Flash, SFC], Separation Mechanism [Adsorption, Partition, Affinity] & End User - Global Forecasts to 2018

The global chromatography market has been segmented into liquid chromatography (LC) and gas chromatography (GC). LC is primarily utilized for commercial applications such as drug development and quality assessment of pharma and biopharma products. Widenning applications are the primary growth driver in this market. Apart from that, the greater efficiency levels offered by LC is another driving factor for this market. On the other hand GC is ruled by Chemicals & Pharmaceuticals end-use sector and forms a major growth driver in this market. Environmental and food safety issues in the developed countries is another major factor driving the market. Europe accounts for the largest share in the GC market, followed by the U.S. and Japan. APAC is expected to register the highest growth.

August 2013 $ 4650 selected

Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018

The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.

August 2013 $ 4650 selected

North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Forecasts To 2017

Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology.

July 2013 $ 4650 selected

European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017

The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes.

July 2013 $ 4650 selected

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018

Aptamers are relatively short (12-30 base) ssDNA or RNA oligonucleotides (or peptides) that were first described in 1980s, represent promising class of therapeutics. Regardless of rising competition from various small molecules and technologies, the aptamer manufacturers/providers foresee an extraordinary growth. Aptamers, typically generated through Systematic Evolution of Ligands by EXponential enrichment (SELEX) have rapidly emerged as a novel and potent class of ligands with exceptional prospective for diagnostic and therapeutic applications.

July 2013 $ 4650 selected

Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017

Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets.

June 2013 $ 4650 selected

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.

June 2013 $ 4650 selected

Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

Patent expiry of major blockbuster drugs is a foremost concern for pharmaceutical companies. Developing a new chemical entity (NCE) is more expensive and time consuming than developing a novel drug delivery technology. Therefore, in recent years many pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in near future.

April 2013 $ 4650 selected

North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

April 2013 $ 4650 selected

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

Globally, injectable medications form the second most preferred class of drugs, with oral route of administration leading the global pharma market. Injectable drug delivery devices have evolved from traditional needles and syringes to recently developed needle-free injectors. The market has evidenced a shifting trend from administration of injections in clinician settings to home care settings, which has resulted in increasing the focus of industry players towards the development of user friendly and patient compliant devices.

April 2013 $ 4650 selected

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently being marketed; 90% of them are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications.

March 2013 $ 4650 selected

Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017)

Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends.

December 2012 $ 4650 selected

Global Biobank (Biospecimen/ Biorepository/Biopreservation) Market for Equipment and Media - Trends and Forecast to 2017

Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. Cryopreservation, vitrification and hypothermic storage are the common biopreservation procedures used widely in laboratory and clinical settings. The increase in cell-banking systems like adult stem cell banking, tissue banking, and umbilical cord blood banking has led to an increase in demand for the concept of biopreservation. Antibodies and proteins obtained from high-yielding cell-lines are required by biotech and pharmaceutical companies for research, diagnostic or clinical purposes. These high-yielding cell lines need to be preserved to give optimum yield, viability and productivity.

October 2012 $ 4650 selected

Biotechnology Reagents Market by Technology (PCR, Cell Culture, Expression & Transfection, Chromatography, Mass Spectrometry, Electrophoresis, & Flow Cytometry), Applications (Protein Purification, Gene Expression, DNA & RNA Analysis, & Drug Testing) and End-Users - Current Trends, Opportunities and Global Forecasts to 2016

Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education.

July 2012 $ 4650 selected

Life Sciences & Analytical Reagents Market - Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016)

The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011.

May 2012 $ 4650 selected

Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis

The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics.

May 2012 $ 4650 selected

Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others) Global Trends, End User & Competitive Analysis

Life science and chemical equipment market is growing at a rapid rate due to the continuous requirement of these instruments in pharmaceutical and biotechnology industries. Besides, the increase in number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and emergence of proteomics have enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity. All these factors are driving the life science and chemical instrumentation market.

February 2012 $ 4650 selected

Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)

The report analyzes the various product segments under the broader biochips market, including lab chips, DNA chips etc. Market analysis includes over 100 market data tables that examine the biochips industry by products and geographies. The report has also profiles the key players and the competitive landscape in detail.

August 2011 $ 4650 selected

Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)

The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.

May 2011 $ 4650 selected

Brazil Biomaterials Market (2010-2015)

Brazil Biomaterials Market is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.

May 2011 $ 4650 selected

Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015

This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.

February 2011 $ 4650 selected

Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.

February 2011 $ 4650 selected

Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015)

The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.

November 2010 $ 4650 selected

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support

US : 1-888-600-6441
UK : 44-800-368-9399

Search reports